Literature DB >> 25984574

The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia.

E L Abner1, F A Schmitt2, P T Nelson3, W Lou4, L Wan5, R Gauriglia6, H H Dodge7, R L Woltjer8, L Yu9, D A Bennett10, J A Schneider, R Chen, K Masaki, M J Katz, R B Lipton, D W Dickson, K O Lim, L S Hemmy, N J Cairns, E Grant, S L Tyas, C Xiong, D W Fardo, R J Kryscio.   

Abstract

Longitudinal cognitive trajectories and other factors associated with mixed neuropathologies (such as Alzheimer's disease with co-occurring cerebrovascular disease) remain incompletely understood, despite being the rule and not the exception in older populations. The Statistical Modeling of Aging and Risk of Transition study (SMART) is a consortium of 11 different high-quality longitudinal studies of aging and cognition (N=11,541 participants) established for the purpose of characterizing risk and protective factors associated with subtypes of age-associated mixed neuropathologies (N=3,001 autopsies). While brain donation was not required for participation in all SMART cohorts, most achieved substantial autopsy rates (i.e., > 50%). Moreover, the studies comprising SMART have large numbers of participants who were followed from intact cognition and transitioned to cognitive impairment and dementia, as well as participants who remained cognitively intact until death. These data provide an exciting opportunity to apply sophisticated statistical methods, like Markov processes, that require large, well-characterized samples. Thus, SMART will serve as an important resource for the field of mixed dementia epidemiology and neuropathology.

Entities:  

Year:  2015        PMID: 25984574      PMCID: PMC4431579     

Source DB:  PubMed          Journal:  Obs Stud        ISSN: 2767-3324


  46 in total

1.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

Authors:  M S Green; J A Kaye; M J Ball
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

4.  The Nun Study: risk factors for pathology and clinical-pathologic correlations.

Authors:  James A Mortimer
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

5.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

6.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

8.  Healthy ageing in the Nun Study: definition and neuropathologic correlates.

Authors:  Suzanne L Tyas; David A Snowdon; Mark F Desrosiers; Kathryn P Riley; William R Markesbery
Journal:  Age Ageing       Date:  2007-09-28       Impact factor: 10.668

9.  Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.

Authors:  John C Morris; Paul S Aisen; Randall J Bateman; Tammie L S Benzinger; Nigel J Cairns; Anne M Fagan; Bernardino Ghetti; Alison M Goate; David M Holtzman; William E Klunk; Eric McDade; Daniel S Marcus; Ralph N Martins; Colin L Masters; Richard Mayeux; Angela Oliver; Kimberly Quaid; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Natalie J Selsor; Reisa A Sperling; Michael W Weiner; Chengjie Xiong; Krista L Moulder; Virginia D Buckles
Journal:  Clin Investig (Lond)       Date:  2012-10-01

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  8 in total

1.  Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.

Authors:  Hiroko H Dodge; Jian Zhu; Randy Woltjer; Peter T Nelson; David A Bennett; Nigel J Cairns; David W Fardo; Jeffrey A Kaye; Deniz-Erten Lyons; Nora Mattek; Julie A Schneider; Lisa C Silbert; Chengjie Xiong; Lei Yu; Frederick A Schmitt; Richard J Kryscio; Erin L Abner
Journal:  Alzheimers Dement       Date:  2016-12-23       Impact factor: 21.566

2.  Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.

Authors:  Erin L Abner; Richard J Kryscio; Frederick A Schmitt; David W Fardo; Daniela C Moga; Eseosa T Ighodaro; Gregory A Jicha; Lei Yu; Hiroko H Dodge; Chengjie Xiong; Randall L Woltjer; Julie A Schneider; Nigel J Cairns; David A Bennett; Peter T Nelson
Journal:  Ann Neurol       Date:  2017-03-22       Impact factor: 10.422

3.  The Effect of Vascular Neuropathology on Late-life Cognition: Results from the SMART Project.

Authors:  R J Kryscio; E L Abner; P T Nelson; D Bennett; J Schneider; L Yu; L S Hemmy; K O Lim; K Masaki; N Cairns; C Xiong; R Woltjer; H H Dodge; S Tyas; D W Fardo; W Lou; L Wan; F A Schmitt
Journal:  J Prev Alzheimers Dis       Date:  2016-06

4.  Multi-state models and missing covariate data: Expectation-Maximization algorithm for likelihood estimation.

Authors:  Wenjie Lou; Lijie Wan; Erin L Abner; David W Fardo; Hiroko H Dodge; Richard J Kryscio
Journal:  Biostat Epidemiol       Date:  2017-04-04

5.  Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology.

Authors:  Erin L Abner; Peter T Nelson; Richard J Kryscio; Frederick A Schmitt; David W Fardo; Randall L Woltjer; Nigel J Cairns; Lei Yu; Hiroko H Dodge; Chengjie Xiong; Kamal Masaki; Suzanne L Tyas; David A Bennett; Julie A Schneider; Zoe Arvanitakis
Journal:  Alzheimers Dement       Date:  2016-01-23       Impact factor: 21.566

6.  Estimation of Multi-state Models with Missing Covariate Values Based on Observed Data Likelihood.

Authors:  Wenjie Lou; Erin L Abner; Lijie Wan; David W Fardo; Richard Lipton; Mindy Katz; Richard J Kryscio
Journal:  Commun Stat Theory Methods       Date:  2018-12-29       Impact factor: 0.863

7.  Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies.

Authors:  Christoforos Hadjichrysanthou; Kevin McRae-McKee; Stephanie Evans; Frank de Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Using Cross-Cultural Studies to Improve Evidence on Dementia Prevention: Lessons from the Special Issue Sponsored by the International Research Network on Dementia Prevention (IRNDP).

Authors:  M Maria Glymour; Rachel A Whitmer
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.